2-(3,4-dimethoxyphenyl)-6-methoxyquinoline-4-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-(3,4-dimethoxyphenyl)-6-methoxyquinoline-4-carboxylic acid
• 化学式: C₁₉H₁₇NO₅
• 分子量: 339.348
• InChiKey: NIXAEHAYWROSEA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.3
• 重原子数：
  25
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.16
• 拓扑面积：
  77.9
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  2-(3,4-dimethoxyphenyl)-6-methoxyquinoline-4-carboxylic acid 在 硫酸 、 一水合肼 、 三乙胺 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 17.0h， 生成 N-(4-acetylphenyl)-2-((5-(2-(3,4-dimethoxyphenyl)-6-methoxyquinolin-4-yl)-4-phenyl-4H-1,2,4-triazol-3-yl)thio)acetamide
  参考文献：
  名称：

  NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth

  摘要：

  Constitutive activation of STAT3 can play a vital role in the development of melanoma. STAT3-targeted therapeutics are reported to show efficacy in melanomas harboring the BRAFV600E mutant and also in vemurafenib-resistant melanomas. We designed and synthesized a series of substituted nitric oxide (NO)-releasing quinolone-1,2,4-triazoleioxime hybrids, hypothesizing that the introduction of a STAT3 binding scaffold would augment their cytotoxicity. All the hybrids tested showed a comparable level of in vitro NO production. 7b and 7c exhibited direct binding to the STAT3-SH domain with IC50 of similar to 0.5 mu M. Also, they abrogated STAT3 tyrosine phosphorylation in several cancer cell lines, including the A375 melanoma cell line that carries the BRAFV600E mutation. At the same time, they did not affect the phosphorylation of upstream kinases or other STAT isoforms. 7c inhibited STAT3 nuclear translocation in mouse embryonic fibroblast while 7b and 7c inhibited STAT3 DNA-binding activity in the A375 cell line. Their anti-proliferating activity is attributed to their ability to trigger the production of reactive oxygen species and induce G1 cell cycle arrest in the A375 cell line. Interestingly, 7b and 7c showed robust cell growth suppression and apoptosis induction in two pairs of BRAF inhibitor-naive (-S) and resistant (-R) melanoma cell lines containing a BRAF V600E mutation. Surprisingly, MEL1617-R cells that are known to be more resistance to MEK inhibition by GSK1120212 than MEL1617-S cells exhibit a similar response to 7b and 7c. (C) 2019 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2019.111885
• 作为产物：
  描述：

  5-甲氧基靛红 、 3,4-二甲氧基苯乙酮 在 potassium hydroxide 作用下， 以 乙醇 为溶剂， 以70%的产率得到2-(3,4-dimethoxyphenyl)-6-methoxyquinoline-4-carboxylic acid
  参考文献：
  名称：

  2-苯基喹啉-4-甲酰胺连接苯磺酰胺衍生物作为跨膜人碳酸酐酶异构体选择性抑制剂的探索

  摘要：

  使用尾部方法合成了一系列新的含有 32 种磺酰胺的喹啉（5a-j、7a-k和9a-k） ，并测定了它们对四种人 (h) 碳酸酐酶 (CA) 异构体 hCA I、II 的碳酸酐酶抑制效力，九和十二。大多数这些新合成的化合物在纳摩尔范围内对 hCA I、II、IX 和 XII 表现出有趣的抑制效力，其中一些衍生物比标准药物乙酰唑胺 ( AAZ ) 更有效。在 hCA I 上最有效的是9b (91.8 nM)，在 hCA II 上：5b ( 7.1 nM)、9c (9.6 nM) 和在 hCA IX 上：5b (6.5 nM) 、5g (21.4 nM), 5i (9.1 nM) , 9a (22.8 nM) , 9b (9.7 nM)。发现化合物5h (8.8 nM)、7a (9.6 nM)、9d (6.9 nM)、9e (6.7 nM) 对 hCA XII 非常有效。发现这些 4-官能化苯磺酰胺

  DOI：

  10.1016/j.ejmech.2022.114247

文献信息

• Synthesis and molecular dynamic simulation studies of novel N-(1-benzylpiperidin-4-yl) quinoline-4-carboxamides as potential acetylcholinesterase inhibitors
  作者：Haniyeh Pashaei、Atiyeh Rouhani、Mojgan Nejabat、Farzin Hadizadeh、Salimeh Mirzaei、Hamid Nadri、Mahdi Faal Maleki、Razieh Ghodsi

  DOI：10.1016/j.molstruc.2021.130919

  日期：2021.11

  reaction. Although docking study of these compounds predicted that they will inhibit acetylcholinesterase (AChE) protein strongly and more than the reference drugs, the in vitro evaluation of the quinolines 5a-5 h revealed that most of them had moderate activity toward AChE. The results showed that there is a correlation between anticholinesterase inhibitory potency and docking energy of compounds. Among these

  设计并合成了一系列新的 N-(1-benzylpiperidin-4-yl) quinoline-4-carboxamide 衍生物作为潜在的乙酰胆碱酯酶抑制剂。通过核磁共振、红外和质谱对化合物进行表征。在添加目标化合物5a -5 h的酰胺化反应中，特别是当我们加入更多的羰基二咪唑（CDI）以完成反应时，也得到了双N-酰基脲。尽管对这些化合物的对接研究预测它们会比参考药物更强烈地抑制乙酰胆碱酯酶 (AChE) 蛋白，但喹啉5a 的体外评估-5 h 表明他们中的大多数人对 AChE 具有中等活性。结果表明，抗胆碱酯酶抑制效力与化合物的对接能之间存在相关性。在这些化合物中，对接能量最低的5f表现出最大的抗胆碱酯酶抑制效力。分子动力学模拟和化合物的分子对接研究5F为乙酰胆碱酯酶的结合位点显示出的可能相互作用5F与乙酰胆碱酯酶的结合位点。
• Holdsworth; Lions, Journal and Proceedings - Royal Society of New South Wales, 1932, vol. 66, p. 273,276
  作者：Holdsworth、Lions

  DOI：——

  日期：——
• NO-releasing STAT3 inhibitors suppress BRAF-mutant melanoma growth
  作者：Tamer S. Kaoud、Aliaa M. Mohassab、Heba A. Hassan、Chunli Yan、Sabrina X. Van Ravenstein、Dalia Abdelhamid、Kevin N. Dalby、Mohamed Abdel-Aziz

  DOI：10.1016/j.ejmech.2019.111885

  日期：2020.1

  Constitutive activation of STAT3 can play a vital role in the development of melanoma. STAT3-targeted therapeutics are reported to show efficacy in melanomas harboring the BRAFV600E mutant and also in vemurafenib-resistant melanomas. We designed and synthesized a series of substituted nitric oxide (NO)-releasing quinolone-1,2,4-triazoleioxime hybrids, hypothesizing that the introduction of a STAT3 binding scaffold would augment their cytotoxicity. All the hybrids tested showed a comparable level of in vitro NO production. 7b and 7c exhibited direct binding to the STAT3-SH domain with IC50 of similar to 0.5 mu M. Also, they abrogated STAT3 tyrosine phosphorylation in several cancer cell lines, including the A375 melanoma cell line that carries the BRAFV600E mutation. At the same time, they did not affect the phosphorylation of upstream kinases or other STAT isoforms. 7c inhibited STAT3 nuclear translocation in mouse embryonic fibroblast while 7b and 7c inhibited STAT3 DNA-binding activity in the A375 cell line. Their anti-proliferating activity is attributed to their ability to trigger the production of reactive oxygen species and induce G1 cell cycle arrest in the A375 cell line. Interestingly, 7b and 7c showed robust cell growth suppression and apoptosis induction in two pairs of BRAF inhibitor-naive (-S) and resistant (-R) melanoma cell lines containing a BRAF V600E mutation. Surprisingly, MEL1617-R cells that are known to be more resistance to MEK inhibition by GSK1120212 than MEL1617-S cells exhibit a similar response to 7b and 7c. (C) 2019 Elsevier Masson SAS. All rights reserved.
• Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases
  作者：Baijayantimala Swain、Santosh Kumar Sahoo、Priti Singh、Andrea Angeli、Venkata Madhavi Yaddanapudi、Claudiu T. Supuran、Mohammed Arifuddin

  DOI：10.1016/j.ejmech.2022.114247

  日期：2022.4

  A novel series of 32 sulfonamide containing quinolines (5a-j, 7a-k and 9a-k) were synthesized using tail approach and assayed for their carbonic anhydrase inhibitory potency against four human (h) carbonic anhydrase (CA) isoforms hCA I, II, IX and XII. Most of these newly synthesized compounds exhibited interesting inhibition potency against hCA I, II, IX and XII, in the nanomolar range with some derivatives

  使用尾部方法合成了一系列新的含有 32 种磺酰胺的喹啉（5a-j、7a-k和9a-k） ，并测定了它们对四种人 (h) 碳酸酐酶 (CA) 异构体 hCA I、II 的碳酸酐酶抑制效力，九和十二。大多数这些新合成的化合物在纳摩尔范围内对 hCA I、II、IX 和 XII 表现出有趣的抑制效力，其中一些衍生物比标准药物乙酰唑胺 ( AAZ ) 更有效。在 hCA I 上最有效的是9b (91.8 nM)，在 hCA II 上：5b ( 7.1 nM)、9c (9.6 nM) 和在 hCA IX 上：5b (6.5 nM) 、5g (21.4 nM), 5i (9.1 nM) , 9a (22.8 nM) , 9b (9.7 nM)。发现化合物5h (8.8 nM)、7a (9.6 nM)、9d (6.9 nM)、9e (6.7 nM) 对 hCA XII 非常有效。发现这些 4-官能化苯磺酰胺